PDB Short entry for 2DY5 HEADER OXIDOREDUCTASE 06-SEP-06 2DY5 TITLE CRYSTAL STRUCTURE OF RAT HEME OXYGENASE-1 IN COMPLEX WITH HEME AND 2- TITLE 2 [2-(4-CHLOROPHENYL)ETHYL]-2-[(1H-IMIDAZOL-1-YL)METHYL]-1,3-DIOXOLANE COMPND MOL_ID: 1; COMPND 2 MOLECULE: HEME OXYGENASE 1; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: C-TERMINAL TRUNCATED FORM; COMPND 5 SYNONYM: HO-1, HSP32; COMPND 6 EC: 1.14.99.3; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: RATTUS NORVEGICUS; SOURCE 3 ORGANISM_COMMON: NORWAY RAT; SOURCE 4 ORGANISM_TAXID: 10116; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 7 EXPRESSION_SYSTEM_STRAIN: JM109; SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 9 EXPRESSION_SYSTEM_PLASMID: PBACE KEYWDS INHIBITOR, SUBSTRATE BOUND STRUCTURE, OXIDOREDUCTASE EXPDTA X-RAY DIFFRACTION AUTHOR M.SUGISHIMA,H.TAKAHASHI,K.FUKUYAMA REVDAT 3 25-OCT-23 2DY5 1 REMARK LINK REVDAT 2 24-FEB-09 2DY5 1 VERSN REVDAT 1 22-MAY-07 2DY5 0 JRNL AUTH M.SUGISHIMA,Y.HIGASHIMOTO,T.OISHI,H.TAKAHASHI,H.SAKAMOTO, JRNL AUTH 2 M.NOGUCHI,K.FUKUYAMA JRNL TITL X-RAY CRYSTALLOGRAPHIC AND BIOCHEMICAL CHARACTERIZATION OF JRNL TITL 2 THE INHIBITORY ACTION OF AN IMIDAZOLE-DIOXOLANE COMPOUND ON JRNL TITL 3 HEME OXYGENASE JRNL REF BIOCHEMISTRY V. 46 1860 2007 JRNL REFN ISSN 0006-2960 JRNL PMID 17253780 JRNL DOI 10.1021/BI062264P REMARK 2 REMARK 2 RESOLUTION. 2.70 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS 1.1 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : ENGH & HUBER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.70 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 50.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 96.6 REMARK 3 NUMBER OF REFLECTIONS : 8758 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.194 REMARK 3 FREE R VALUE : 0.248 REMARK 3 FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 FREE R VALUE TEST SET COUNT : 480 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.70 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.80 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 84.70 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL REMARK 3 BIN R VALUE (WORKING SET) : 0.2855 REMARK 3 BIN FREE R VALUE : 0.3049 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : 42 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 1742 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 64 REMARK 3 SOLVENT ATOMS : 10 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 61.10 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 50.15 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -4.79100 REMARK 3 B22 (A**2) : -4.79100 REMARK 3 B33 (A**2) : 9.58300 REMARK 3 B12 (A**2) : -14.10800 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.30 REMARK 3 ESD FROM SIGMAA (A) : 0.38 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.37 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.42 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.010 REMARK 3 BOND ANGLES (DEGREES) : NULL REMARK 3 DIHEDRAL ANGLES (DEGREES) : 18.61 REMARK 3 IMPROPER ANGLES (DEGREES) : 0.723 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : ISOTROPIC REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : NULL REMARK 3 KSOL : NULL REMARK 3 BSOL : NULL REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : NULL REMARK 3 TOPOLOGY FILE 1 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 2DY5 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 08-SEP-06. REMARK 100 THE DEPOSITION ID IS D_1000025988. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 12-JUL-06 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SPRING-8 REMARK 200 BEAMLINE : BL41XU REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0000 REMARK 200 MONOCHROMATOR : SI(111) DOUBLE MONOCHROMATOR REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 8774 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.700 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 97.4 REMARK 200 DATA REDUNDANCY : 7.400 REMARK 200 R MERGE (I) : 0.09100 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 10.6000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.70 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.80 REMARK 200 COMPLETENESS FOR SHELL (%) : 93.1 REMARK 200 DATA REDUNDANCY IN SHELL : 7.60 REMARK 200 R MERGE FOR SHELL (I) : 0.31900 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: MOLREP REMARK 200 STARTING MODEL: PDB ENTRY 1IVJ REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 51.79 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.55 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 4.2M SODIUM FORMATE, 50MM POTTASIUM REMARK 280 PHOSPHATE, PH 7.0, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE REMARK 280 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 32 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z+2/3 REMARK 290 3555 -X+Y,-X,Z+1/3 REMARK 290 4555 Y,X,-Z REMARK 290 5555 X-Y,-Y,-Z+1/3 REMARK 290 6555 -X,-X+Y,-Z+2/3 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 80.92667 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 40.46333 REMARK 290 SMTRY1 4 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 4 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 5 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 40.46333 REMARK 290 SMTRY1 6 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 6 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 80.92667 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 300 REMARK: THE BIOLOGICAL ASSYMBLY IS A MONOMER IN THE ASYMMETRIC UNIT. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 1 REMARK 465 GLU A 2 REMARK 465 ARG A 3 REMARK 465 PRO A 4 REMARK 465 GLN A 5 REMARK 465 LEU A 6 REMARK 465 ASP A 7 REMARK 465 SER A 8 REMARK 465 MET A 9 REMARK 465 GLU A 224 REMARK 465 HIS A 225 REMARK 465 LYS A 226 REMARK 465 ASP A 227 REMARK 465 GLN A 228 REMARK 465 SER A 229 REMARK 465 PRO A 230 REMARK 465 SER A 231 REMARK 465 GLN A 232 REMARK 465 THR A 233 REMARK 465 GLU A 234 REMARK 465 PHE A 235 REMARK 465 LEU A 236 REMARK 465 ARG A 237 REMARK 465 GLN A 238 REMARK 465 ARG A 239 REMARK 465 PRO A 240 REMARK 465 ALA A 241 REMARK 465 SER A 242 REMARK 465 LEU A 243 REMARK 465 VAL A 244 REMARK 465 GLN A 245 REMARK 465 ASP A 246 REMARK 465 THR A 247 REMARK 465 THR A 248 REMARK 465 SER A 249 REMARK 465 ALA A 250 REMARK 465 GLU A 251 REMARK 465 THR A 252 REMARK 465 PRO A 253 REMARK 465 ARG A 254 REMARK 465 GLY A 255 REMARK 465 LYS A 256 REMARK 465 SER A 257 REMARK 465 GLN A 258 REMARK 465 ILE A 259 REMARK 465 SER A 260 REMARK 465 THR A 261 REMARK 465 SER A 262 REMARK 465 SER A 263 REMARK 465 SER A 264 REMARK 465 GLN A 265 REMARK 465 THR A 266 REMARK 465 PRO A 267 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 VAL A 42 107.40 -161.26 REMARK 500 TYR A 74 -42.32 -137.99 REMARK 500 ALA A 75 -51.37 -25.15 REMARK 500 HIS A 100 49.28 -100.11 REMARK 500 REMARK 500 REMARK: NULL REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 HEM A 300 FE REMARK 620 N RES CSSEQI ATOM REMARK 620 1 HIS A 25 NE2 REMARK 620 2 HEM A 300 NA 88.9 REMARK 620 3 HEM A 300 NB 92.2 90.0 REMARK 620 4 HEM A 300 NC 90.8 179.2 89.2 REMARK 620 5 HEM A 300 ND 87.8 90.4 179.6 90.4 REMARK 620 6 224 A 301 N2 177.0 88.2 88.7 92.1 91.3 REMARK 620 N 1 2 3 4 5 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CL A 302 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE HEM A 300 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 224 A 301 DBREF 2DY5 A 1 267 UNP P06762 HMOX1_RAT 1 267 SEQRES 1 A 267 MET GLU ARG PRO GLN LEU ASP SER MET SER GLN ASP LEU SEQRES 2 A 267 SER GLU ALA LEU LYS GLU ALA THR LYS GLU VAL HIS ILE SEQRES 3 A 267 ARG ALA GLU ASN SER GLU PHE MET ARG ASN PHE GLN LYS SEQRES 4 A 267 GLY GLN VAL SER ARG GLU GLY PHE LYS LEU VAL MET ALA SEQRES 5 A 267 SER LEU TYR HIS ILE TYR THR ALA LEU GLU GLU GLU ILE SEQRES 6 A 267 GLU ARG ASN LYS GLN ASN PRO VAL TYR ALA PRO LEU TYR SEQRES 7 A 267 PHE PRO GLU GLU LEU HIS ARG ARG ALA ALA LEU GLU GLN SEQRES 8 A 267 ASP MET ALA PHE TRP TYR GLY PRO HIS TRP GLN GLU ALA SEQRES 9 A 267 ILE PRO TYR THR PRO ALA THR GLN HIS TYR VAL LYS ARG SEQRES 10 A 267 LEU HIS GLU VAL GLY GLY THR HIS PRO GLU LEU LEU VAL SEQRES 11 A 267 ALA HIS ALA TYR THR ARG TYR LEU GLY ASP LEU SER GLY SEQRES 12 A 267 GLY GLN VAL LEU LYS LYS ILE ALA GLN LYS ALA MET ALA SEQRES 13 A 267 LEU PRO SER SER GLY GLU GLY LEU ALA PHE PHE THR PHE SEQRES 14 A 267 PRO SER ILE ASP ASN PRO THR LYS PHE LYS GLN LEU TYR SEQRES 15 A 267 ARG ALA ARG MET ASN THR LEU GLU MET THR PRO GLU VAL SEQRES 16 A 267 LYS HIS ARG VAL THR GLU GLU ALA LYS THR ALA PHE LEU SEQRES 17 A 267 LEU ASN ILE GLU LEU PHE GLU GLU LEU GLN ALA LEU LEU SEQRES 18 A 267 THR GLU GLU HIS LYS ASP GLN SER PRO SER GLN THR GLU SEQRES 19 A 267 PHE LEU ARG GLN ARG PRO ALA SER LEU VAL GLN ASP THR SEQRES 20 A 267 THR SER ALA GLU THR PRO ARG GLY LYS SER GLN ILE SER SEQRES 21 A 267 THR SER SER SER GLN THR PRO HET CL A 302 1 HET HEM A 300 43 HET 224 A 301 20 HETNAM CL CHLORIDE ION HETNAM HEM PROTOPORPHYRIN IX CONTAINING FE HETNAM 224 1-({2-[2-(4-CHLOROPHENYL)ETHYL]-1,3-DIOXOLAN-2- HETNAM 2 224 YL}METHYL)-1H-IMIDAZOLE HETSYN HEM HEME HETSYN 224 2-[2-(4-CHLOROPHENYL)ETHYL]-2-[(1H-IMIDAZOL-1-YL) HETSYN 2 224 METHYL]-1,3-DIOXOLANE FORMUL 2 CL CL 1- FORMUL 3 HEM C34 H32 FE N4 O4 FORMUL 4 224 C15 H17 CL N2 O2 FORMUL 5 HOH *10(H2 O) HELIX 1 1 ASP A 12 ASN A 30 1 19 HELIX 2 2 SER A 31 GLN A 38 1 8 HELIX 3 3 SER A 43 LYS A 69 1 27 HELIX 4 4 TYR A 74 TYR A 78 5 5 HELIX 5 5 PHE A 79 HIS A 84 1 6 HELIX 6 6 ARG A 85 GLY A 98 1 14 HELIX 7 7 HIS A 100 ALA A 104 5 5 HELIX 8 8 THR A 108 HIS A 125 1 18 HELIX 9 9 LEU A 128 GLY A 144 1 17 HELIX 10 10 GLN A 145 ALA A 156 1 12 HELIX 11 11 LEU A 164 THR A 168 5 5 HELIX 12 12 ASN A 174 ASN A 187 1 14 HELIX 13 13 THR A 192 THR A 222 1 31 LINK NE2 HIS A 25 FE HEM A 300 1555 1555 2.23 LINK FE HEM A 300 N2 224 A 301 1555 1555 2.19 SITE 1 AC1 2 ARG A 27 ARG A 185 SITE 1 AC2 14 LYS A 18 HIS A 25 GLU A 29 MET A 34 SITE 2 AC2 14 TYR A 134 GLY A 139 SER A 142 LEU A 147 SITE 3 AC2 14 LYS A 179 ARG A 183 PHE A 207 ASN A 210 SITE 4 AC2 14 PHE A 214 224 A 301 SITE 1 AC3 9 MET A 34 PHE A 37 VAL A 50 GLY A 139 SITE 2 AC3 9 ASP A 140 GLY A 143 LEU A 147 PHE A 167 SITE 3 AC3 9 HEM A 300 CRYST1 66.780 66.780 121.390 90.00 90.00 120.00 P 32 2 1 6 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.014975 0.008646 0.000000 0.00000 SCALE2 0.000000 0.017291 0.000000 0.00000 SCALE3 0.000000 0.000000 0.008238 0.00000